Implementation Guide CH VACD
4.0.1 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Immunization: TCA1 Immunization by patient

Generated Narrative: Immunization

Resource Immunization "TCA01-IMMUN1-patient"

Profile: CH VACD Immunization

Author of the content: Patient/TC-patient " WEGMUELLER"

CH VACD Extension Immunization Medication Reference: Medication/TC-IMMUN-MEDIC-HAVRIX1440

identifier: id: acc1f090-5e0c-45ae-b283-521d57c3aa2f

status: completed

vaccineCode: Havrix 1440 (Swiss Medic Authorized Vaccines Codesystem#558)

patient: Patient/TC-patient " WEGMUELLER"

occurrence: 2021-06-01

recorded: 2021-06-02 00:00:00+0200

lotNumber: AHAVB946A

route: Intramuscular use (standardterms.edqm.eu#20035000)

Performers

-Actor
*PractitionerRole/TC-HCP1-ORG1-ROLE-performer

note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-01)

ProtocolApplieds

-TargetDiseaseDoseNumber[x]
*Viral hepatitis, type A (disorder) (SNOMED CT#40468003)1